| Code |
| SQBB |
| Title |
| Bristol-Myers Squibb Indonesia (common stock) |
| Address |
| Head Office | : | | | Address | : | Wisma Tamara, 10th Floor | | | Jl. Jend. Sudirman Kav. 24 - Jakarta 12920 | | Phone | : | (021) 520 6720 | | Fax | : | (021) 520 6735 | | E-mail | : | dyah.budiastuti@ma.taisho.co.id | | Website | : | www.taisho.co.id | | Factory | : | | | | Jl. Raya Jakarta - Bogor Km. 38 Cilangkap | | | Cibinong - Bogor | | Phone | : | (021) 875 2583 - 84 | | Fax | : | (021) 875 2585 | | E-mail | : | | | Website | : | |
|
| Background |
The Company activities are to develop, register, process, produce and sell chemical, pharmaceutical and health care products. |
| Business cp product |
The Company activities are to develop, register, process, produce and sell chemical, pharmaceutical and health care products. |
| Subsidiary affiliation |
|
| Commissioners |
| President Commissioner | : Masahiro Mino | | | Commissioner | : Naoaki Sugano | | | Commissioner | : Agoes Soewandono | | | | | | Per 30 Sep 2017 | | |
|
| Directors |
| President Director | : Jun Kuroda | | | Director | : Masashi Nakaura | | | Director | : Adeel Akhlaq Hassan | | | | | | Per 30 Sep 2017 | | |
|
| Underwriter |
| PT. Merincorp | | PT. Danareksa | | PT. Multicor | | | |
| Share registrar |
| PT. Blue Chip Mulia | | | PT. Bima Registra | |
| Share holders |
| Common Shareholder : | Shares | % | | | | Taisho Pharmaceutical Co.,Ltd. | 9268000 | 91.00% | | | | Preferred Shareholder : | | | | | | Taisho Pharmaceutical Co.,Ltd. | 764240 | 7.00% | | | | Public (< 5%) | 207760 | 2.00% | | | | | | | | | Per 30 Sep 2017 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares Company Listing18-Apr-01100022680002268000 Additional List29-Apr-03100070000009268000
|
| Other infos |
PT. Bristol-Myers Squibb Indonesia Tbk |
| Created date |
| 2017-11-21 11:37:05 |
| Revised date |
| 2017-11-21 11:37:05 |
| Finance |
| Bristol-Myers Squibb Indonesia (common stock) |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|